Pricing Log in Create free account

Bio-Techne Corp (TECH) vs TG Therapeutics, Inc. (TGTX)

Bio-Techne Corp and TG Therapeutics, Inc. are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $8.9B — 1.3× the size. TG Therapeutics, Inc. trades at the lower P/E: 19.1× against 62.2×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against −0.38%. TG Therapeutics, Inc. has the higher net margin (55.2% vs 15.0%) and the higher return on invested capital (10.7% vs 7.70%). Across the 22 metrics below, Bio-Techne Corp leads on 12 and TG Therapeutics, Inc. on 10.

Valuation

Metric TECH TGTX Biotechnology median
P/E 62.15 19.11 10.26
P/S 9.33 10.30 9.18
P/B 5.38 13.64 2.05
Price to free cash flow 43.09 473.79 24.81
EV/EBITDA 32.32 62.00 0.65
EV/Sales 9.29 10.54 8.98
Earnings yield 1.61% 5.23% (34.89%)
Free cash flow yield 2.32% 0.21% (24.52%)

Profitability

Metric TECH TGTX Biotechnology median
Gross margin 65.77% 82.37% 65.16%
Operating margin 20.73% 17.05% 0.00%
Net margin 14.97% 55.22% 0.00%
Free cash flow margin 21.66% 2.17% 0.00%
Return on equity 9.03% 100.28% (50.12%)
Return on assets 7.07% 37.70% (45.60%)
Return on invested capital 7.70% 10.69% 0.00%

Growth

Metric TECH TGTX Biotechnology median
Revenue growth (TTM) (0.38%) 76.08% 6.26%
EPS growth (last fiscal year) 152.17% 1,746.67% 29.88%
Revenue growth, 5-year CAGR 5.47% 426.73% 9.75%
Net income growth, 5-year CAGR 5.31% 0.00% 0.00%

Health

Metric TECH TGTX Biotechnology median
Debt to equity 0.09 1.23 0.00
Current ratio 4.55 4.27 4.89
Net debt to EBITDA (0.19) 0.86 1.01

Dividend

Metric TECH TGTX Biotechnology median
Dividend yield 0.44% — 0.41%
Payout ratio 0.28 — —

Size

Metric TECH TGTX Biotechnology median
Market cap 11.41b 8.87b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack